TIGIT and neoplasm: Before HBV/HCV mediated tumor initiation, TIGIT expression helps in maintaining the immune tolerance in hepatic tissue so that there is minimal immune mediated pathology, however, sustained expression of TIGIT promotes the progression of tumor by diminishing anti-tumor immunity.